申请人:Rhone-Poulenc Sante
公开号:US05026717A1
公开(公告)日:1991-06-25
Compounds of formula: ##STR1## and their salts, in which R.sub.1 represents polyfluoroalkoxy, and R.sub.2 represents alkyl, alkenyl (3-6 C), [cycloalkyl (3-6 C)]-alkyl, carbamoylalkyl, dialkylcarbamoylalkyl, acylaminoalkyl, phenylthioalkyl, hydroxyalkyl, cyanoalkyl, sulphamoylethyl, N-alkylsulphamoylethyl, pyridylthioalkyl, pyridiylalkylthioalkyl, pyridylsulphinylalkyl, alkynyl (3-6 C), phenylsulphinylalkyl, halophenylthioalkyl, (2,2,2-trifluoroethylthio)alkyl, 2-dialkylaminopropyl, pyrimidinylsulphinylalkyl, pyridylalkylsulphinylalkyl, halophenylsulphinylalkyl or (2,2,2-trifluoroethylsulphinyl)alkyl are useful in the treatment of medical conditions associated with the effects of glutamate.
式为##STR1##的化合物及其盐,其中R.sub.1代表多氟烷氧基,R.sub.2代表烷基、烯基(3-6 C)、[环烷基(3-6 C)]-烷基、氨基甲基、二烷基氨基甲基、酰基氨基烷基、苯硫基烷基、羟基烷基、氰基烷基、磺酰基乙基、N-烷基磺酰基乙基、吡啶基硫基烷基、吡啶基烷基硫基烷基、吡啶基磺酰基烷基、炔基(3-6 C)、苯基磺酰基烷基、卤代苯基硫基烷基、(2,2,2-三氟乙基硫基)烷基、2-二烷基氨基丙基、嘧啶基磺酰基烷基、吡啶基烷基磺酰基烷基、卤代苯基磺酰基烷基或(2,2,2-三氟乙基磺酰基)烷基在治疗与谷氨酸作用有关的医疗病症中有用。